Taher AT, Al-Samkari H, Aydinok Y, Besser M, et al. Mitapivat in adults with non-transfusion-dependent alpha-thalassaemia or beta-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial. Lancet 2025;406:33-42.
PMID: 40544857